Nowadays, it is strongly believed that 68Ga- or 18F-labeled PSMA PET-CT and PSMA PET-MRI represent a valid diagnostic instrument that is able to improve the management of many patients with both primary and recurrent PCa [85]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.